Guiyang Xintian Pharmaceutical: Notice on obtaining a trademark registration certificate
Apr 26 12:00 ET
Xintian Pharmaceutical: Announcement on Further Explanation of the 2023 Profit Distribution Plan
Apr 16 12:00 ET
Xintian Pharmaceutical: Comparative Table of Amendments to the Articles of Association
Apr 11 12:00 ET
Xintian Pharmaceutical: Report of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties by the Audit Committee
Apr 11 12:00 ET
Xintian Pharmaceutical: Announcement on Hiring a 2024 Financial and Internal Control Auditor
Apr 11 12:00 ET
Xintian Pharmaceutical: Internal Control Self-Assessment Report
Apr 11 12:00 ET
Xintian Pharmaceutical: Announcement on Organizational Structure Adjustments
Apr 11 12:00 ET
Xintian Pharmaceutical: Notice of Annual General Meeting of Shareholders
Apr 11 12:00 ET
Xintian Pharmaceutical: Announcement on holding an online briefing on the 2023 annual results
Apr 11 12:00 ET
Xintian Pharmaceutical: Announcement on the Resignation of Deputy General Manager
Apr 11 12:00 ET
Xintian Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the first quarter of 2024
Apr 1 12:00 ET
Xintian Pharmaceutical: Announcement on foreign investment to establish wholly-owned subsidiaries and complete industrial and commercial registration
Mar 14 12:00 ET
Xintian Pharmaceutical: Announcement on Abnormal Stock Trading Fluctuations and Risk Alerts
Mar 12 12:00 ET
Xintian Pharmaceutical: Announcement on Abnormal Fluctuations in Xintian Bond Transfer Transactions
Mar 11 12:00 ET
Xintian Pharmaceutical: Instructions of the board of directors that this restructuring complies with the provisions of Articles 11 and 43 of the “Administrative Measures on Major Asset Reorganization of Listed Companies”
Mar 7 11:00 ET
Xintian Pharmaceutical: Explanation of the confidentiality measures and confidentiality system adopted by the board of directors on this major asset restructuring
Mar 7 11:00 ET
Xintian Pharmaceutical: Announcement on the resumption of trading of the company's shares, the resumption of trading of convertible corporate bonds, and the conversion of shares
Mar 7 11:00 ET
Xintian Pharmaceutical: Explanation of the Board of Directors on the purchase and sale of assets within 12 months prior to the restructuring
Mar 7 11:00 ET
Xintian Pharmaceutical: Explanation of the board of directors on the completeness and compliance of the legal procedures and the validity of the submitted legal documents in this restructuring
Mar 7 11:00 ET
Xintian Pharmaceutical: Announcement on the shareholding information of the top ten shareholders on the previous trading day before issuing shares to purchase assets and related transactions were suspended
Mar 7 11:00 ET
No Data
No Data